USLM Stock Analysis: United States Lime | NASDAQ
Building Materials | NASDAQ, USA | Market Cap: 3.083m USD | 12M Return: -5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 28.8M
EPS Trend: -89.5%
Rev. Trend: 98.5%
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
United States Lime & Minerals, Inc. (NASDAQ: USLM) is a Dallas-based producer of lime and limestone products, extracting raw material from open-pit quarries and an underground mine for processing into pulverized limestone, quicklime, hydrated lime, and lime slurry. The company serves a diversified customer base across construction (highway, road, and building contractors), industrial manufacturing (paper, glass, steel), environmental services (water and flue gas treatment), oil and gas services, roof shingle production, and poultry production. In addition to its core lime operations, the company holds royalty interests in natural gas wells in the Barnett Shale Formation in Johnson County, Texas, providing a non-operating source of revenue tied to oil and gas production. Founded in 1950 and listed since 1990, USLM operates as a subsidiary of Inberdon Enterprises Ltd.
As a member of the Materials sector, USLM is positioned in the Construction Materials sub-industry, where demand is closely linked to infrastructure spending, commercial construction activity, and environmental regulatory requirements that drive consumption of lime in emissions control and water treatment. Lime is a relatively commodity-like product, and producers in this space typically compete on logistics, proximity to reserves, and the ability to serve bulk industrial customers with consistent supply.
- Federal infrastructure spending lifts highway lime volumes
- Oilfield services activity drives lime slurry demand
- Natural gas and coal costs pressure kiln operating margins
| Net Income: 130.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -4.77 > 1.0 |
| NWC/Revenue: 122.7% < 20% (prev 107.6%; Δ 15.13% < -1%) |
| CFO/TA 0.22 > 3% & CFO 157.6m > Net Income 130.7m |
| Net Debt (-379.5m) to EBITDA (192.7m): -1.97 < 3 |
| Current Ratio: 20.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.8m) vs 12m ago 0.18% < -2% |
| Gross Margin: 48.13% > 18% (prev 47.25%; Δ 0.88% > 0.5%) |
| Asset Turnover: 56.86% > 50% (prev 57.63%; Δ -0.77% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.64 (Total Current Assets 476.3m - Total Current Liabilities 23.0m) / Total Assets 713.8m |
| B: 0.94 (Retained Earnings 671.9m / Total Assets 713.8m) |
| C: 0.26 (EBIT TTM 167.0m / Avg Total Assets 649.5m) |
| D: 12.55 (Book Value of Equity 661.2m / Total Liabilities 52.7m) |
| Altman-Z'' = 22.14 = AAA |
| DSRI: 0.95 (Receivables 58.1m/55.8m, Revenue 369.3m/337.3m) |
| GMI: 0.98 (GM 47.25% / 48.13%) |
| AQI: 9.66 (AQ_t 0.01 / AQ_t-1 0.00) |
| SGI: 1.09 (Revenue 369.3m / 337.3m) |
| TATA: -0.04 (NI 130.7m - CFO 157.6m) / TA 713.8m) |
| Beneish M = 2.12 (Cap -4..+1) = D |
As of July 10, 2026, the stock is trading at USD 99.20 with a total of 203,018 shares traded. Over the past week, the price has changed by -6.44%, over one month by -7.68%, over three months by -27.15% and over the past year by -4.98%.
Current recommended Stop Loss: 93.30 (which is 5.9% or 1.3 ATR below the current price).
United States Lime has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold USLM.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 130 | 31% |
P/E Trailing = 23.6784
P/E Forward = 15.2439
P/S = 8.3489
P/B = 4.5997
Revenue TTM = 369.3m USD
EBIT TTM = 167.0m USD
EBITDA TTM = 192.7m USD
Long Term Debt = 2.01m USD (estimated: total debt 3.63m - short term 1.62m)
Short Term Debt = 1.62m USD (from shortTermDebt, last quarter)
Debt = 3.63m USD (from shortLongTermDebtTotal, last quarter) (leases 3.63m already included)
Net Debt = -379.5m USD (calculated: Debt 3.63m - CCE 383.2m)
Enterprise Value = 2.70b USD (3.08b + Debt 3.63m - CCE 383.2m)
Interest Coverage Ratio = unknown (Ebit TTM 167.0m / Interest Expense TTM 0.0)
EV/FCF = 29.58x (Enterprise Value 2.70b / FCF TTM 91.4m)
FCF Yield = 3.38% (FCF TTM 91.4m / Enterprise Value 2.70b)
FCF Margin = 24.75% (FCF TTM 91.4m / Revenue TTM 369.3m)
Net Margin = 35.40% (Net Income TTM 130.7m / Revenue TTM 369.3m)
Gross Margin = 48.13% ((Revenue TTM 369.3m - Cost of Revenue TTM 191.6m) / Revenue TTM)
Gross Margin QoQ = 47.54% (prev 47.86%)
Tobins Q-Ratio = 3.79 (Enterprise Value 2.70b / Total Assets 713.8m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 3.63m)
Taxrate = 21.73% (36.3m / 167.0m)
NOPAT = 130.7m (EBIT 167.0m * (1 - 21.73%))
Current Ratio = 20.73 (Total Current Assets 476.3m / Total Current Liabilities 23.0m)
Debt / Equity = 0.01 (Debt 3.63m / totalStockholderEquity, last quarter 661.2m)
Debt / EBITDA = -1.97 (Net Debt -379.5m / EBITDA 192.7m)
Debt / FCF = -4.15 (Net Debt -379.5m / FCF TTM 91.4m)
Total Stockholder Equity = 614.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 20.13% (Net Income 130.7m / Total Assets 713.8m)
RoE = 21.28% (Net Income TTM 130.7m / Total Stockholder Equity 614.4m)
RoCE = 27.10% (EBIT 167.0m / Capital Employed (Equity 614.4m + L.T.Debt 2.01m))
RoIC = 19.40% (NOPAT 130.7m / Invested Capital 674.0m)
WACC = 10.39% (E(3.08b)/V(3.09b) * Re(10.40%) + D(3.63m)/V(3.09b) * Rd(0.0%) * (1-Tc(0.22)))
Discount Rate = 10.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 96.61 | Cagr: 0.33%
[DCF] Terminal Value 66.68% ; FCFF base≈96.0m ; Y1≈87.4m ; Y5≈76.0m
[DCF] Fair Price = 44.76 (EV 904.2m - Net Debt -379.5m = Equity 1.28b / Shares 28.7m; r=10.39% [WACC]; 5y FCF grow -11.12% → 2.50% )
EPS Correlation: -89.52 | EPS CAGR: -38.56% | SUE: N/A | # QB: 0
Revenue Correlation: 98.49 | Revenue CAGR: 14.64% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.30 | Chg30d=+4.00% | Revisions=+25% | Analysts=1
EPS next Quarter (2026-09-30): EPS=1.48 | Chg30d=-2.63% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=5.14 | Chg30d=-5.51% | Revisions=+25% | GrowthEPS=+10.1% | GrowthRev=+14.3%
EPS next Year (2027-12-31): EPS=5.84 | Chg30d=-5.50% | Revisions=+25% | GrowthEPS=+13.6% | GrowthRev=+13.6%